Covid-19 Impact on Global Irritable Bowel Syndrome (IBS) Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Irritable Bowel Syndrome (IBS) Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
1.4 Market Analysis by Type
1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 IBS-D Drug
1.4.3 IBS-C Drug
1.4.4 Other
1.5 Market by Application
1.5.1 Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2020 VS 2026
1.5.2 Women
1.5.3 Men
1.6 Coronavirus Disease 2019 (Covid-19): Irritable Bowel Syndrome (IBS) Industry Impact
1.6.1 How the Covid-19 is Affecting the Irritable Bowel Syndrome (IBS) Industry
1.6.1.1 Irritable Bowel Syndrome (IBS) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Irritable Bowel Syndrome (IBS) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Irritable Bowel Syndrome (IBS) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Irritable Bowel Syndrome (IBS) Market Perspective (2015-2026)
2.2 Irritable Bowel Syndrome (IBS) Growth Trends by Regions
2.2.1 Irritable Bowel Syndrome (IBS) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Share by Regions (2015-2020)
2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Irritable Bowel Syndrome (IBS) Market Growth Strategy
2.3.6 Primary Interviews with Key Irritable Bowel Syndrome (IBS) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Market Size
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2015-2020)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2015-2020)
3.1.3 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio
3.2.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2019
3.3 Irritable Bowel Syndrome (IBS) Key Players Head office and Area Served
3.4 Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
3.5 Date of Enter into Irritable Bowel Syndrome (IBS) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2015-2020)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2021-2026)
5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application (2015-2026)
5.1 Global Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2015-2020)
6.2 Irritable Bowel Syndrome (IBS) Key Players in North America (2019-2020)
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2015-2020)
7.2 Irritable Bowel Syndrome (IBS) Key Players in Europe (2019-2020)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
8 China
8.1 China Irritable Bowel Syndrome (IBS) Market Size (2015-2020)
8.2 Irritable Bowel Syndrome (IBS) Key Players in China (2019-2020)
8.3 China Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
8.4 China Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Irritable Bowel Syndrome (IBS) Market Size (2015-2020)
9.2 Irritable Bowel Syndrome (IBS) Key Players in Japan (2019-2020)
9.3 Japan Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
9.4 Japan Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size (2015-2020)
10.2 Irritable Bowel Syndrome (IBS) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
10.4 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
11 India
11.1 India Irritable Bowel Syndrome (IBS) Market Size (2015-2020)
11.2 Irritable Bowel Syndrome (IBS) Key Players in India (2019-2020)
11.3 India Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
11.4 India Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Irritable Bowel Syndrome (IBS) Market Size (2015-2020)
12.2 Irritable Bowel Syndrome (IBS) Key Players in Central & South America (2019-2020)
12.3 Central & South America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020)
12.4 Central & South America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview and Its Total Revenue
13.1.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
13.1.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 Bausch Health
13.2.1 Bausch Health Company Details
13.2.2 Bausch Health Business Overview and Its Total Revenue
13.2.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
13.2.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020)
13.2.5 Bausch Health Recent Development
13.3 Takeda
13.3.1 Takeda Company Details
13.3.2 Takeda Business Overview and Its Total Revenue
13.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
13.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020)
13.3.5 Takeda Recent Development
13.4 Sucampo Pharmaceuticals
13.4.1 Sucampo Pharmaceuticals Company Details
13.4.2 Sucampo Pharmaceuticals Business Overview and Its Total Revenue
13.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
13.4.4 Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020)
13.4.5 Sucampo Pharmaceuticals Recent Development
13.5 McNeil Consumer Healthcare
13.5.1 McNeil Consumer Healthcare Company Details
13.5.2 McNeil Consumer Healthcare Business Overview and Its Total Revenue
13.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Introduction
13.5.4 McNeil Consumer Healthcare Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020)
13.5.5 McNeil Consumer Healthcare Recent Development
13.6 Sebela Pharmaceuticals
13.6.1 Sebela Pharmaceuticals Company Details
13.6.2 Sebela Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
13.6.4 Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020)
13.6.5 Sebela Pharmaceuticals Recent Development
13.7 Astellas Pharmaceuticals
13.7.1 Astellas Pharmaceuticals Company Details
13.7.2 Astellas Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
13.7.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020)
13.7.5 Astellas Pharmaceuticals Recent Development
13.8 IM HealthScience
13.8.1 IM HealthScience Company Details
13.8.2 IM HealthScience Business Overview and Its Total Revenue
13.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Introduction
13.8.4 IM HealthScience Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020)
13.8.5 IM HealthScience Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Irritable Bowel Syndrome (IBS) Key Market Segments
Table 2. Key Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
Table 3. Ranking of Global Top Irritable Bowel Syndrome (IBS) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of IBS-D Drug
Table 6. Key Players of IBS-C Drug
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Irritable Bowel Syndrome (IBS) Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Irritable Bowel Syndrome (IBS) Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Irritable Bowel Syndrome (IBS) Players to Combat Covid-19 Impact
Table 13. Global Irritable Bowel Syndrome (IBS) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Irritable Bowel Syndrome (IBS) Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Irritable Bowel Syndrome (IBS) Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2015-2020)
Table 17. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Irritable Bowel Syndrome (IBS) Market Growth Strategy
Table 23. Main Points Interviewed from Key Irritable Bowel Syndrome (IBS) Players
Table 24. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2015-2020) (Million US$)
Table 25. Global Irritable Bowel Syndrome (IBS) Market Share by Players (2015-2020)
Table 26. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2019)
Table 27. Global Irritable Bowel Syndrome (IBS) by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
Table 30. Date of Enter into Irritable Bowel Syndrome (IBS) Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$)
Table 33. Global Irritable Bowel Syndrome (IBS) Market Size Share by Type (2015-2020)
Table 34. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2021-2026)
Table 35. Global Irritable Bowel Syndrome (IBS) Market Size Share by Application (2015-2020)
Table 36. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$)
Table 37. Global Irritable Bowel Syndrome (IBS) Market Size Share by Application (2021-2026)
Table 38. North America Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020)
Table 40. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$)
Table 41. North America Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020)
Table 42. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$)
Table 43. North America Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020)
Table 44. Europe Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020)
Table 46. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020)
Table 48. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020)
Table 50. China Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$)
Table 51. China Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020)
Table 52. China Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$)
Table 53. China Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020)
Table 54. China Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$)
Table 55. China Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020)
Table 56. Japan Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020)
Table 58. Japan Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020)
Table 60. Japan Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020)
Table 64. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020)
Table 66. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020)
Table 68. India Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$)
Table 69. India Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020)
Table 70. India Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$)
Table 71. India Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020)
Table 72. India Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$)
Table 73. India Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020)
Table 76. Central & South America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020)
Table 78. Central & South America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020)
Table 80. Allergan Company Details
Table 81. Allergan Business Overview
Table 82. Allergan Product
Table 83. Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$)
Table 84. Allergan Recent Development
Table 85. Bausch Health Company Details
Table 86. Bausch Health Business Overview
Table 87. Bausch Health Product
Table 88. Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$)
Table 89. Bausch Health Recent Development
Table 90. Takeda Company Details
Table 91. Takeda Business Overview
Table 92. Takeda Product
Table 93. Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$)
Table 94. Takeda Recent Development
Table 95. Sucampo Pharmaceuticals Company Details
Table 96. Sucampo Pharmaceuticals Business Overview
Table 97. Sucampo Pharmaceuticals Product
Table 98. Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$)
Table 99. Sucampo Pharmaceuticals Recent Development
Table 100. McNeil Consumer Healthcare Company Details
Table 101. McNeil Consumer Healthcare Business Overview
Table 102. McNeil Consumer Healthcare Product
Table 103. McNeil Consumer Healthcare Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$)
Table 104. McNeil Consumer Healthcare Recent Development
Table 105. Sebela Pharmaceuticals Company Details
Table 106. Sebela Pharmaceuticals Business Overview
Table 107. Sebela Pharmaceuticals Product
Table 108. Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$)
Table 109. Sebela Pharmaceuticals Recent Development
Table 110. Astellas Pharmaceuticals Company Details
Table 111. Astellas Pharmaceuticals Business Overview
Table 112. Astellas Pharmaceuticals Product
Table 113. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$)
Table 114. Astellas Pharmaceuticals Recent Development
Table 115. IM HealthScience Business Overview
Table 116. IM HealthScience Product
Table 117. IM HealthScience Company Details
Table 118. IM HealthScience Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$)
Table 119. IM HealthScience Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2020 VS 2026
Figure 2. IBS-D Drug Features
Figure 3. IBS-C Drug Features
Figure 4. Other Features
Figure 5. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2020 VS 2026
Figure 6. Women Case Studies
Figure 7. Men Case Studies
Figure 8. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 9. Global Irritable Bowel Syndrome (IBS) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Irritable Bowel Syndrome (IBS) Market Share by Regions: 2020 VS 2026
Figure 11. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2019
Figure 14. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2019
Figure 16. North America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Allergan Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020)
Figure 25. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020)
Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Takeda Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020)
Figure 29. Sucampo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Sucampo Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020)
Figure 31. McNeil Consumer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. McNeil Consumer Healthcare Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020)
Figure 33. Sebela Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sebela Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020)
Figure 35. Astellas Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020)
Figure 37. IM HealthScience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. IM HealthScience Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs